Massive Transfusion Protocol Online Training

INSTRUCTIONS - Start Here

This online interactive learning module reviews key points of massive transfusion protocol (MTP) triggering, testing and termination. This module highlights current MTP protocols and use of information technology to assist with clinical practice.

 

Credit to Kristin Lease from OL&D's Instructional Design Team for designing the module.

1. Demonstrate appropriate identification of cases that qualify for massive transfusion protocol
2. Discuss requiring laboratory testing for massive transfusion protocol patients and proper interpretation of testing results
3. Discuss proper timing for massive transfusion protocol termination and notification procedures to Blood Bank

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours), Act 13 Patient Safety/Risk Management Credits (1.00 hours)

Wednesday, April 13, 2022, 12:01 AM - Sunday, December 31, 2023, 11:59 PM

Accreditation Statement: WellSpan Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. 

Credit Designation: WellSpan Health designates this Enduring Material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty participating in continuing medical education programs sponsored by WellSpan Health are expected to disclosure to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).

Mitigation of Relevant Financial Relationships

WellSpan Health CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.